111 related articles for article (PubMed ID: 11247624)
1. Use of the Autopap as a primary automated cervical cancer screening system.
Willey BB; Matz LR
Med J Aust; 2001 Feb; 174(3):151-2. PubMed ID: 11247624
[No Abstract] [Full Text] [Related]
2. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
[TBL] [Abstract][Full Text] [Related]
4. Automated cervical cytology: meta-analyses of the performance of the AutoPap 300 QC System.
Abulafia O; Sherer DM
Obstet Gynecol Surv; 1999 Jul; 54(7):469-76. PubMed ID: 10394585
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of automated systems for the analysis of cervical smears.
Coleman DV
Cytopathology; 1998 Dec; 9(6):359-68. PubMed ID: 9861528
[No Abstract] [Full Text] [Related]
6. The primary screening clinical trials of the TriPath AutoPap System.
Wilbur DC; Norton MK
Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
Walts AE; Thomas P
Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
[TBL] [Abstract][Full Text] [Related]
8. Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK.
Willis BH; Barton P; Pearmain P; Bryan S; Hyde C
Health Technol Assess; 2005 Mar; 9(13):1-207, iii. PubMed ID: 15774236
[TBL] [Abstract][Full Text] [Related]
9. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
Wilbur DC; Parker EM; Foti JA
Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
[TBL] [Abstract][Full Text] [Related]
10. By the way, doctor. I read with interest your article regarding conventional Pap smears, PapNet, and AutoPap. Lately I've been reading about another test called ThinPrep. I'm not sure which one to request. Which of these techniques is better for detecting cervical cancer?
Robb-Nicholson C
Harv Womens Health Watch; 1999 Aug; 6(12):8. PubMed ID: 10402327
[No Abstract] [Full Text] [Related]
11. Automation of primary screening for cervical cancer. Sooner or later?
Bartels PH; Vooijs GP
Acta Cytol; 1999; 43(1):7-12. PubMed ID: 9987443
[No Abstract] [Full Text] [Related]
12. [The use of a computerised system in the reading of cytological cervicovaginals smears during programming of regional screening (one year of experience using the autopap system)].
Orlassino R; Fabbrini T; Gallo C; Vineis C
Pathologica; 2005 Apr; 97(2):78-83. PubMed ID: 16032952
[TBL] [Abstract][Full Text] [Related]
13. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
Colgan TJ; Patten SF; Lee JS
Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the performance of the AutoPap 300 QC system with optimal staining and presentation of cervical smears.
Colgan TJ; Smith J; Patten SF; Lee JS
Acta Cytol; 1997; 41(1):50-5. PubMed ID: 9022726
[TBL] [Abstract][Full Text] [Related]
16. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
Wertlake P
J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
[TBL] [Abstract][Full Text] [Related]
17. Screening of cervical cancer: where do we go from here?
Kuo DY; Goldberg GL
Cancer Invest; 2003; 21(1):157-61. PubMed ID: 12643017
[No Abstract] [Full Text] [Related]
18. Economic impact of automated primary screening for cervical cancer.
Smith BL; Lee M; Leader S; Wertlake P
J Reprod Med; 1999 Jun; 44(6):518-28. PubMed ID: 10394546
[TBL] [Abstract][Full Text] [Related]
19. Nasseem Husain: homage to a pioneer of cytology automation.
Kocjan G; Herbert A
Cytopathology; 2015 Aug; 26(4):211-6. PubMed ID: 26223502
[TBL] [Abstract][Full Text] [Related]
20. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team.
Lancet; 1999 Apr; 353(9162):1381-5. PubMed ID: 10227217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
